Drugs / Oxycodone-Acetaminophen
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT04246541 | Apr 2019 → Sep 2021 | musculoskeletal system disorder, substance-related disorder | University Hospitals Cleveland Medical Center | Completed | No outcome recorded |
| Comparator or background therapy5 trials | ||||||
| Phase 1 | NCT04112550 Comparator | Feb 2020 → Dec 2021 | intervertebral disk degenerative disorder, spondylolisthesis | The Methodist Hospital Research Institute | Unknown | No outcome recorded |
| Phase 2/3 | NCT07709598 Comparator | May → Oct 2026 expected | — | Shanghai Huilun Pharmaceutical Co., Ltd. | Recruiting | No outcome recorded |
| Phase 2/3 | NCT04939987 Comparator | Aug → Oct 2022 | — | Wake Forest University Health Sciences | Withdrawn | No outcome recorded |
| Phase 3 | NCT04872283 Comparator | May 2019 → Dec 2021 | — | Rothman Institute Orthopaedics | Unknown | No outcome recorded |
| Phase 3 | NCT03584373 Comparator | Jul 2018 → Mar 2022 | nephrolithiasis | Montefiore Medical Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | oxycodone-acetaminophen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04246541 ↗ |
| Route | Oral | “oxycodone/acetaminophen 10/325 po tablet pre-operatively” NCT04112550 ↗ |